docetaxel anhydrous has been researched along with butyric acid in 1 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (butyric acid) | Trials (butyric acid) | Recent Studies (post-2010) (butyric acid) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 3,556 | 85 | 1,448 |
Protein | Taxonomy | docetaxel anhydrous (IC50) | butyric acid (IC50) |
---|---|---|---|
Histone deacetylase 3 | Homo sapiens (human) | 9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, G; Lu, Y; Ma, D; Wang, S; Wu, P; Xi, L; Xu, G; Xu, Q; Yang, W; Zhang, A; Zhou, J; Zhu, T | 1 |
1 other study(ies) available for docetaxel anhydrous and butyric acid
Article | Year |
---|---|
Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway.
Topics: Animals; Apoptosis; Butyric Acid; Cisplatin; Cytochromes c; Docetaxel; Drug Administration Schedule; HeLa Cells; Humans; Mice; Mice, Nude; Mitochondria; Taxoids; Telomerase; Telomere; Xenograft Model Antitumor Assays | 2006 |